10-Q: Verano Holdings Reports Q2 2026 Results: Revenue Up, Margins Down

Sentiment:

Quarterly Report


Verano Holdings Corp. announced its second quarter 2026 financial results, showing an 8% increase in revenue but a decline in gross profit margin and a wider net loss compared to the prior year period.

Worse than expectedGross profit margin decreased from 56% to 46% year-over-year, indicating increased cost of goods sold relative to revenue.Net loss attributable to Verano Holdings Corp. increased from $13.4 million to $19.2 million year-over-year for the three months ended June 30.Cost of Goods Sold increased by 32.4% for the three months ended June 30, 2026, outpacing revenue growth.Selling, General, and Administrative Expenses increased by 7% for the three months ended June 30, 2026.

Summary

  • Verano Holdings Corp. reported revenues of $217.9 million for the three months ended June 30, 2026, an 8% increase from $202.3 million in the same period of 2025.
  • Gross profit decreased to $99.7 million (46% margin) from $113.0 million (56% margin) year-over-year.
  • Net loss attributable to Verano Holdings Corp. widened to $13.4 million ($0.18 per share) from $19.2 million ($0.27 per share) in the prior year's quarter.
  • For the six months ended June 30, 2026, revenues increased by 3% to $426.1 million, while gross profit decreased to $198.7 million (47% margin) from $212.6 million (52% margin).
  • The net loss for the six-month period increased slightly to $31.2 million ($0.43 per share) from $30.7 million ($0.43 per share) in the prior year.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative sentiment due to declining gross profit margins and an increased net loss, despite revenue growth. The ongoing uncertainty surrounding cannabis rescheduling and its tax implications also contributes to a cautious outlook.

Positives

  • Revenue increased by 8% to $217.9 million for the three months ended June 30, 2026, driven by new product momentum and operational improvements.
  • Revenue for the six months ended June 30, 2026, increased by 3% to $426.1 million.
  • The company opened one new retail store in Florida during the three-month period and three new stores during the six-month period.
  • Cash flow from operating activities improved significantly, increasing from $12.7 million in the first six months of 2025 to $49.2 million in the same period of 2026.
  • The company's working capital increased to $294.9 million as of June 30, 2026, from $264.4 million as of December 31, 2025.

Negatives

  • Gross profit margin declined to 46% in Q2 2026 from 56% in Q2 2025, primarily due to price compression in the wholesale segment.
  • Net loss attributable to Verano Holdings Corp. was $13.4 million for Q2 2026, an increase from the $19.2 million net loss in Q2 2025.
  • Cost of goods sold increased by 32.4% to $118.2 million in Q2 2026 compared to the prior year.
  • Selling, General, and Administrative (SG&A) expenses increased by 7% to $92.5 million in Q2 2026.
  • An impairment loss of $4.1 million was recorded on a held-for-sale cultivation facility in Massachusetts.

Risks

  • The ongoing federal illegality of cannabis in the U.S. and the evolving regulatory landscape, including potential changes in federal law and enforcement.
  • The uncertainty surrounding the rescheduling of medical cannabis and its impact on tax implications (Section 280E), with formal IRS guidance pending.
  • Price compression in the third-party cultivation (wholesale) segment, which has impacted gross profit margins.
  • Increased competition and promotional activity in key third-party wholesale markets, such as Connecticut.
  • Potential for challenges to the recent April Final Order reclassifying medical cannabis to Schedule III, including ongoing litigation.
  • Reliance on key management personnel and potential for operational and execution risks associated with growth.

Future Outlook

The company expects continued revenue growth driven by new product momentum and operational improvements. However, it anticipates ongoing pressure on margins within the cultivation (wholesale) and retail segments due to market maturation and competition. The impact of potential federal cannabis rescheduling on tax liabilities remains a key area of focus and uncertainty.

Management Comments

  • The company's strategy is to vertically integrate as a single cohesive company in multiple states through the consolidation of seed-to-sale cultivating, manufacturing, distributing, and dispensing of cannabis brands and products at scale.
  • The company's model includes establishing a diverse geographic footprint that allows us to adapt to changes in both industry and market conditions.
  • In the core markets in which the Company is already operational and, as the state markets mature, the Company has experienced pressure on margins within the cultivation (wholesale) and retail segments and expects this to continue.

Industry Context

StockSavvy.ai notes that Verano Holdings operates within the highly regulated and rapidly evolving U.S. cannabis industry. The recent executive order and subsequent actions by the Justice Department to reschedule medical cannabis to Schedule III represent a significant potential shift, particularly regarding the impact of Section 280E tax implications. However, the adult-use market remains under federal prohibition, and legal challenges to the rescheduling order introduce ongoing uncertainty.

Comparison to Industry Standards

  • Verano's revenue growth of 8% in Q2 2026 is in line with the general growth trend observed in the U.S. cannabis retail sector, which has seen consistent expansion.
  • The decline in gross profit margin from 56% to 46% is a concern and may indicate greater price compression than experienced by some competitors who have managed to maintain higher margins through product differentiation or cost controls.
  • The company's net loss, while widened in Q2 2026, is a common characteristic for many multi-state operators (MSOs) in the U.S. cannabis industry due to high operating costs, regulatory burdens, and tax inefficiencies (like Section 280E).
  • The significant improvement in operating cash flow is a positive indicator and suggests better operational efficiency compared to the previous year, a trend that is crucial for sustainable growth in the industry.

Legal Proceedings

  • In May 2026, several petitions were filed challenging the April Final Order reclassifying medical cannabis to Schedule III, along with a motion to stay the order. The outcome of this litigation is uncertain.

Related Party Transactions

  • George Archos, CEO, funded $10,000 of the 2026 Credit Agreement through an affiliated entity.
  • Lease payments were made for properties from entities where George Archos holds an indirect ownership interest (740 Rte. 59, LLC and 783 Butterfield LLC).
  • A new lease agreement was entered into with Fernandina Beach Management, LLC, in which George Archos holds an indirect ownership interest.
  • Sweed High Tech Holdings, Inc., a provider of point of sale software, has a less than 1% ownership interest held by an entity controlled by George Archos.
  • John Tipton, a former President of the Southern Region, entered into a consulting agreement and received RSUs and monthly payments.

Stakeholder Impact

  • Shareholders may be concerned by the declining gross profit margins and widening net loss, despite revenue growth.
  • The uncertainty surrounding federal cannabis rescheduling and its tax implications could impact future profitability and investor confidence.
  • Employees may be affected by ongoing operational adjustments and the company's expansion strategy.
  • Suppliers and creditors will be monitoring the company's financial performance and liquidity, particularly given the debt obligations.

Next Steps

  • Continue to expand retail presence, including opening new stores.
  • Focus on new product momentum and strategic collaborations to broaden brand offerings.
  • Monitor and adapt to evolving federal and state regulatory landscapes, particularly concerning cannabis rescheduling.
  • Manage operational costs and address price compression in the wholesale segment.
  • Evaluate the impact of ongoing litigation challenging the April Final Order on cannabis rescheduling.

Key Dates

DateDescription
2025-03-12Filing of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
2025-10-27Company's stockholders approved the Plan of Arrangement for the Continuance.
2025-10-30Supreme Court of British Columbia issued a Final Order for the Continuance.
2025-11-03Completion of the Continuance from British Columbia to Nevada.
2026-01-12First Amendment to Credit Agreement and Omnibus First Amendment to Credit Documents for the Revolver.
2026-03-11Repayment of all amounts owing under the 2022 Credit Agreement and drawing of $50,000 under the Revolver.
2026-03-11Entry into the 2026 Credit Agreement.
2026-04-23Justice Department issued the April Final Order reclassifying medical cannabis from Schedule I to Schedule III.
2026-04-26Effective date of the April Final Order.
2026-04-30Public announcement of the Company's share repurchase program.
2026-06-11Company effected a 1-for-5 reverse stock split.
2026-06-29New hearing on the proposed rule for rescheduling cannabis began.
2026-07-15Evidentiary hearing for cannabis rescheduling concluded.
2026-08-03As of this date, the registrant had 73,217,970 shares of Common Stock outstanding.
2026-08-05Date of the Form 10-Q filing.

Recommendation

hold

Verano Holdings shows revenue growth and improved operating cash flow, which are positive. However, declining gross margins, increased net loss, and significant operational expenses, coupled with the persistent uncertainty in the U.S. cannabis regulatory and tax environment (especially regarding Section 280E), warrant a cautious approach. The company is navigating a complex landscape where potential regulatory shifts could be beneficial but also carry risks. A 'hold' recommendation reflects the balance between growth potential and the significant headwinds and uncertainties present.

Keywords

cannabis, multi-state operator, retail, cultivation, wholesale, financial results, revenue, gross profit

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.